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Abstract Agrin is a heparan sulfate proteoglycan that
is best known for its crucial involvement in the organi-
zation and maintenance of postsynaptic structures at
the neuromuscular junction. Consistent with this role,
mice deWcient of agrin die at birth due to respiratory
failure. Here we examined the early postnatal develop-
ment of agrin-deWcient mice in which perinatal death
was prevented by transgenic expression of neural agrin
in motor neurons. Such transgenic, agrin-deWcient mice
were born at Mendelian ratio but exhibited severe
postnatal growth retardation. Growth plate morpholgy
was markedly altered in these mice, with changes being
most prominent in the hypertrophic zone. Compres-
sion of this zone was not caused by reduced viability of
hypertrophic chondrocytes, as no diVerences in the
apoptosis rates could be observed. Furthermore, depo-
sition of the major cartilage matrix components colla-
gen type II and aggrecan was slightly reduced in these
mice. Consistent with a role for agrin in skeletal devel-
opment, we show for the Wrst time that agrin is highly
expressed by chondrocytes and localizes to the growth
plate in wild-type mice. Our data show that agrin is
expressed in cartilage and that it plays a critical role in
normal skeletal growth.
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Introduction
Bone develops via either endochondral or intramem-
branous ossiWcation, starting with condensation of mes-
enchymal cells in both situations (Karaplis 2002;
Kronenberg 2003). In endochondral ossiWcation, the
mechanism by which long bones are formed, there
remains a cartilagenous growth plate at the epiphysis
which is responsible for longitudinal bone growth. The
arrangement of chondrocytes in these growth plates is
highly organized, with zones of resting, proliferating,
and hypertrophic cells. Bone growth is accomplished
mainly by two mechanisms, by proliferation of chon-
drocytes and by their enlargement when they become
hypertrophic. It has been estimated that in mice this
process of hypertrophy accounts for approximately
80% of the total growth rate (Vanky et al. 1998).
It is obvious that proper skeletal bone formation and
growth critically depend on a tight regulation of the
processes occurring at the growth plate. Both systemic
and local factors contribute to this regulation (van der
Eerden et al. 2003). Among the locally acting systems
the Indian hedgehog/parathyroid hormone-related pro-
tein (PTHrP) system and the Wbroblast growth factor
(FGF) system involving FGF receptor 3 (FGFR3) are
the best characterized, but other signaling molecules
such as transforming growth factor (TGF)-s, bone
morphogenetic proteins (BMPs), and wnt proteins have
been shown to contribute, too. Disturbances in these
regulatory systems characteristically interfere with nor-
mal skeletal development. For example, activating
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to several skeletal dysplasias, including achondroplasia
(Rousseau et al. 1994), the most common genetic form
of dwarWsm in humans, hypochondroplasia (Bellus
et al. 1995), and thanatophoric dysplasia (Tavormina
et al. 1995). DwarWsm is also an overt phenotype in
transgenic mice expressing constitutively active FGFR3
in their growth plates. In these mice, both the hypertro-
phic and the proliferative zones are signiWcantly smaller
than in their littermate controls, though overall histo-
morphologic architecture of the growth plates is not
dramatically altered (Naski et al. 1998).
Agrin is a heparan sulfate proteoglycan that was iso-
lated from basal lamina-rich extracts of the electric
organ of the paciWc ray Torpedo californica (Nitkin et al.
1987) based on its activity to induce clustering of acetyl-
choline receptors (AChRs) on cultured muscle cells. Its
core protein has a predicted molecular mass of 225 kDa
and is composed of protein modules that are also found
in other ECM proteins. Importantly, alternative mRNA
splicing at several sites gives rise to protein isoforms
(Ruegg et al. 1992; Rupp et al. 1992). Alternative splic-
ing at the most carboxy-terminal site, called B in chick
and z in rodents, aVects AChR-aggregating activity
(Ferns et al. 1993; Gesemannet al. 1995; Ruegg et al.
1992). In particular, only agrin isoforms with amino acid
inserts at this B/z-site (agrin-B/z+) can induce AChR
aggregation, while isoforms devoid of an amino acid
insert (agrin-B/z¡) lack this activity. Agrin is crucial for
the formation and maintenance of postsynaptic special-
izations at the neuromuscular junction (NMJ), as agrin
mutant mice do not form a proper NMJ and therefore
die at birth due to respiratory failure (Gautam et al.
1996; Lin et al. 2001). Similarly, mice that are unable to
synthesize agrin-B/z+ and thus only express agrin-B/z¡
also die at birth (Burgess et al. 1999). These experiments
are the formal proof that agrin-B/z+ is an essential factor
released from motor neurons to induce the formation
and maintenance of postsynapses at the NMJ as had
been predicted by the agrin hypothesis (McMahan
1990). Agrin’s function in the formation of postsynaptic
structures requires the muscle-speciWc kinase MuSK
(DeChiara et al. 1996; Glass et al. 1996), which forms an
essential component of an agrin receptor complex.
Agrin protein is not conWned to the NMJ but is
expressed in several tissues including muscle (Lieth
et al. 1992), kidney (GroVen et al. 1998), brain (O’Con-
nor et al. 1994) and immune system (Khan et al. 2001).
Here we set out to study functions of agrin during early
postnatal development outside of the NMJ. To this
end, we generated transgenic mice that express agrin-
B/z+ in motor neurons and mated them with agrin-deW-
cient mice. We show that the resulting transgenic
agrin-deWcient mice survive but exhibit pronounced
postnatal growth retardation. Furthermore, we show
that this growth retardation is accompanied by compo-
sitional and structural alterations of the growth plate,
suggesting functional impairment of the chondrocytes
to be responsible for the eVects of agrin-deWciency on
growth. Moreover, we demonstrate that agrin is
expressed by chondrocytes and is deposited in the
growth plate. Thus, our experiments establish an
unprecedented function of agrin in skeletal growth.
Materials and methods
Generation of Tg/agrn¡/¡ mice
Rescued agrin-deWcient mice that express a basement
membrane-bound neural isoform of chick agrin (con-
taining a four amino acid insert at the A/y site and an
eight amino acid insert at the B/z site) under the con-
trol of the 9 kb motor neuron-speciWc Hb9 promotor
were generated as described elsewhere (I. Ksiazek
et al., manuscript in preparation.). In short, mice
expressing the transgene were mated with heterozy-
gous agrin-deWcient mice (Lin et al. 2001), giving rise
to transgenic, heterozygous agrin-deWcient oVsprings.
These mice were again mated with heterozygous agrin-
deWcient mice, yielding homozygous agrin-deWcient
mice expressing the transgene. Tg/agrn¡/¡ mice lacked
all endogenous agrin isoforms but they expressed chick
neural agrin in motor neurons.
Chondrocyte cell culture
Chondrocytes were obtained from articular cartilage of
3-week-old mice by sequential digestion with 0.2%
pronase for 1 h and 0.025% collagenase overnight,
both in DMEM without addition of fetal bovine serum.
Released chondrocytes were cultured in HAM’s F-12/
DMEM (1:1) containing 10% FBS (Biochrom, Berlin).
By means of RT-PCR, these cells were shown to
express collagen type II, aggrecan, and COMP.
RT-PCR
Total RNA was extracted from cultured cells using the
RNeasy Mini Kit (Qiagen, Hilden, Germany), and
digested with RNase-free DNase (Qiagen) to remove
any contaminating genomic DNA. cDNA synthesis
from total RNA was performed with Omniscript
reverse transcriptase (Qiagen) using (dT)15 (1 M) and
random hexanucleotide primers (5 M; Roche
Diagnostics, Mannheim, Germany) simultaneously.123
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StarTaq DNA polymerase (Qiagen) and the primers
speciWed in Table 1. All primers were synthesized by
MWG Biotech (Munich, Germany) and were of high
purity salt free (HPSF)-quality. The polymerase was
activated (15 min at 96°C) and then up to 40 cycles
(45 s at 94°C, 45 s at 60°C, 45 s at 72°C) were per-
formed on a RoboCycler Gradient 96 (Stratagene,
Amsterdam, The Netherlands). AmpliWcation products
were visualized by agarose gel electrophoresis after
staining with ethidium bromide. Images were acquired
using the ImageMaster VDS system (Amersham Bio-
sciences, Freiburg, Germany) and the accompanying
software (version 2.0).
Histological analysis
Specimens for conventional histological examinations
and for immunohistochemistry were Wxed in 4%
buVered formaldehyde for at least 72 h. After rinsing
with water they were decalciWed in 10% EDTA solu-
tion, pH 7.4, for up to 6 weeks. 3.5 m sections were
cut from paraYn-embedded tissue and routinely
stained with hematoxylin/eosin (HE), safranin O/fast-
green (SO), alcian blue at pH 1.0 (AB), and by the
Masson-Goldner (MG) trichrome staining procedure
(Goldner 1938).
Immunohistochemistry
To improve immunoreactivity, deparaVinized samples
were incubated for 4 min at ambient temperature with
1 mg/ml pronase in 9 mM CaCl2, pH 7.8 (for the detec-
tion of agrin and collagen type X); for 30 min at 37°C
with 1 mg/ml pepsin in 0.5 M acetic acid (for the detec-
tion of collagen type II); for 30 min at 37°C with
20 munits chondroitinase ABC (Seikagaku, Tokyo) in
50 mM Tris–HCl, pH 8.0, containing 50 mM sodium
acetate and 0.1% bovine serum albumine, followed by
10 min with 2 mg/ml hyaluronidase (from bovine testis;
Sigma, Taufkirchen) in 10 mM sodium citrate, pH 6.0,
and 20 min at 37°C with 0.1% Triton X-100 in PBS (for
the detection of aggrecan); and by boiling for 10 min in
10 mM sodium citrate, pH 6.0 [for the detection of pro-
liferating cell nuclear antigen (PCNA)]. Subsequently
the samples were rinsed with phosphate-buVered saline
and incubated for 30 min at ambient temperature with
3% H2O2 to inactivate endogenous peroxidase activity.
After blocking nonspeciWc protein binding sites with
protein block solution (DAKO, Hamburg), samples
were incubated with primary antibody for 2 h at 37°C.
For immunolocalization of agrin a polyclonal rabbit
antiserum raised against the C-terminus of mouse agrin
(Eusebio et al. 2003) was used, type X collagen was
immunolocalized using the monoclonal antibody X 53
(Girkontaite et al.1996), type II collagen with the
monoclonal antibody collagen II Ab-3, clone 6B3 (Lab
Vision, Fremont), aggrecan with a polyclonal rabbit
anti-aggrecan antibody (Chemicon, Hampshire), and
PCNA with the monoclonal antibody PCNA Ab-1,
clone PC10 (NeoMarkers, Fremont). Bound mouse
antibodies were visualized using the LSAB kit
(DAKO) and 3-amino-9-ethylcarbazol (AEC; DAKO)
as chromogen according to the instructions of the man-
ufacturer, bound rabbit antibodies were visualized by
subsequent incubations with biotinylated goat-anti rab-
bit antibody (1:1,000; Santa Cruz Biotechnology, Santa
Cruz), the streptavidin-conjugated horseradish peroxi-
dase of the LSAB kit, and 3-amino-9-ethylcarbazol as
substrate. As a negative control sections were pro-
cessed in the absence of primary antibody.
Terminal deoxynucleotide transferase-mediated dUTP 
nick end labeling (TUNEL) assay
For permeabilization, deparaVinized tissue sections
were incubated for 8 min at ambient temperature with
0.1% Triton X-100 in 4 mM sodium citrate. After
Table 1 Primers used for RT-PCR
Target Accesion Product 
size(s)
Upstream primer Downstream primer
Agrin 
(14/15)
NM_021604 184 5-CAATGAATGCCAGCTGAAGA-3 5-GTGCTGGGAGACAGAGGAAG-3
Agrin 
19/20
NM_021604 208, 235 5-CATGTGCGATTCTTGGACTTT-3 5-GAGTCCGAGGTCGGTCAATA-3
Agrin 
27/29
NM_021604 200, 212 5-GGCACCTGGGTTAGGGTATT-3 5-GGATGGCACCATCAAAGC-3
Agrin 
31/34
NM_021604 184, 208, 
217, 241
5-CAGTGGGGGACCTAGAAACA-3 5-GCCATGTAGTCTGCACGTTCT-3
MuSK NM_010944 193 5-CATTCTGAGCGTGGAAGACA-3 5-TTTGGGGTTACCCATCGTAG-3
GAPDH NM_001001303 73 5-CGTGTTCCTACCCCCAATGT-3 5-TGTCATCATACTTGGCAGGTTTCT-3123
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for 1 h at 37°C with a TUNEL reaction mixture pre-
pared from TUNEL Enzyme (Roche Diagnostics,
Penzberg) and TUNEL Label (Roche Diagnostics)
according to the instructions of the manufacturer. For
positive control, sections were preincubated with
DNase I (55 U/ml in 50 mM Tris–HCl, pH 7.5, contain-
ing 0.1% bovine serum albumine) for 10 min at ambi-
ent temperature. Negative controls were incubated
with TUNEL Label solution without terminal deoxy-
nucleotide transferase (TUNEL Enzyme). Incorpo-
rated Xuorescein-labeled dUTP was visualized by
Xuorescence microscopy.
Image acquisition
Microscopy was performed with a Zeiss Axioskop 2
microscope (Zeiss, Munich, Germany) equipped with a
Zeiss AxioCam MRc digital camera, using the accom-
panying image acquisition software (AxioVision 3.1).
Roentgenological examination of killed mice was
performed using mammography equipment (Senogra-
phe DMR, General Electric Healthcare, Solingen)
using Kodak MIN-R2000 Wlms. For digitalization
images were reproduced to Illford Pan F Wlm (ISO 50)
and scanned with a Nikon Super Coolscan 4000 ED
Wlm scanner using the SiverFast Ai 6 software.
Results
Growth retardation of rescued agrin deWcient mice
Agrin deWciency in mice leads to perinatal death due to
severe impairment of neuromuscular function (Gau-
tam et al. 1996; Lin et al. 2001). As neural agrin
released from motor neurons is responsible for proper
formation of the NMJ, we decided to generate mice
that express full-length chick neural agrin under the
control of the promoter of motor neuron-speciWc
homeodomain factor Hb9 (Arber et al. 1999; Thaler
et al. 1999). Transgenic mice were selected that
expressed the protein in all motor neurons and were
mated with heterozygous agrin knockout mice to
obtain transgenic agrin mutant mice (Tg/agrn¡/¡)
(I. Ksiazek et al., manuscript in preparation). Tg/agrn¡/¡
mice were born at Mendelian ratio and, in contrast to
agrin knockout mice, survived for up to 3 months.
However, they were much smaller than their control
littermates. While control mice gained approximately
0.5 g/day in the Wrst 40 days and then continued to
grow with a slower growth rate of 0.1 g/day, the growth
of Tg/agrn¡/¡ mice was reduced by 50%. Moreover,
after 4 weeks no further growth could be observed in
Tg/agrn¡/¡ mice (Fig. 1).
This growth retardation suggested changes in bone
morphology of Tg/agrn¡/¡ mice. We therefore exam-
ined the mice with X-ray and found a shortening of the
long bones and the spine, but the bones proper seemed
not to be malformed (Fig. 2). The total length of the
spine was reduced by approximately 19% in mice from
2 to 8 weeks of age, femur and tibia were reduced by 15
and 8%, respectively. Because no diVerences were seen
between wild-type mice and heterozygous agrin knock-
out mice, irrespective of whether they expressed the
transgene or not, both were used in the following
experiments as controls.
Agrin is expressed by chondrocytes and is deposited 
into in the growth plate
Since agrin has not been reported to be expressed in
skeletal tissue, we next examined expression of agrin
in chondrocytes. To this end we Wrst isolated articular
cartilage chondrocytes from 3-week-old wild-type
mice and looked for agrin expression by RT-PCR
using primers speciWc for mouse agrin that bind in
non-alternatively spliced regions. As shown in Fig. 3a,
mouse chondrocytes indeed express agrin. Similarly,
expression of agrin could also be detected in human
articular chondrocytes (data not shown). Though
chondrocytes from articular cartilage are not the cells
that are responsible for bone growth, this observation
Fig. 1 Growth retardation of Tg/agrn¡/¡ mice. Growth of control
mice (open circles) and Tg/agrn¡/¡ mice (Wlled circles) was deter-
mined by weight measurement. Early postnatal growth was
approximately 0.5 g/day in control mice and 0.25 g/day in agrin-
deWcient mice. Whereas control mice continued to grow, the
growth of Tg/agrn¡/¡ mice stagnated after 4 weeks123
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as well.
Bone growth is best characterized in long bones,
where longitudinal growth is accomplished mainly by
chondrocyte proliferation and hypertrophy in the
epiphyseal growth plate. Therefore, we further con-
centrated on the growth plates of femur and tibia.
Immunostaining revealed that agrin was indeed pres-
ent in femoral growth plates from 4-day-old mice.
Staining was predominantly matrix-associated and
was most prominent in the zones of proliferating and
prehypertrophic chondrocytes, but was also found in
the zone of resting chondrocytes (Fig. 3b). No speciWc
staining could be observed in growth plates from Tg/
agrn¡/¡ mice (Fig. 3c). Agrin staining in the growth
plate persisted throughout maturation (data not
shown).
Growth plate morphology is altered in Tg/agrn¡/¡ mice
To evaluate whether agrin deWciency aVected the
growth plate, we next performed histological analysis
of Tg/agrn¡/¡ and control mice at various stages of
postnatal development (Fig. 4). At postnatal day 4
(P4), the thickness of the hypertrophic zone was
reduced by approximately 30% in Tg/agrn¡/¡ mice,
while the thickness of the proliferative zone was
unchanged. This reduction in the size of the hypertro-
phic zone became more pronounced with age, and at
P53 a continuous hypertrophic zone was no longer
detectable (Fig. 4m–p). At sites where hypertrophic
chondrocytes were still present at this age, the thick-
ness of this “hypertrophic zone” was reduced by
approximately 50%. At P4, we could not detect a
diVerence in safranin-O and alcian blue stainings
(Fig. 4c, g; d, h). However, at P53 both stainings were
weaker in Tg/agrn¡/¡ mice (Fig. 4k, o; l, p), suggesting
a decreased glycosaminoglycan content. Furthermore,
the weaker Masson-Goldner staining (Fig. 4j, n) in
Tg/agrn¡/¡ mice indicated a decrease in the collagen
content, too.
As the consequence of agrin deWciency was most
evident in the hypertrophic zone of the growth plate,
we decided to look whether expression of collagen X
is aVected in Tg/agrn¡/¡ mice. This matrix molecule is
speciWcally expressed by hypertrophic chondrocytes
and serves as a marker for hypertrophic diVerentia-
tion. Apart from the already described changes in the
thickness of the hypertrophic zone, there was no obvi-
ous diVerence in the matrix staining for collagen X in
6-day-old Tg/agrn¡/¡ mice (Fig. 5a, b), indicating
proper hypertrophic diVerentiation. However, we
observed a delay in the formation of the secondary
ossiWcation center of the proximal tibia (Fig. 5d, e),
suggesting a delayed diVerentiation to hypertrophic
chondrocytes.
Matrix composition is altered in Tg/agrn¡/¡ growth 
plates
The histochemical stainings described above indicated
that growth plates from Tg/agrn¡/¡ mice might contain
reduced amounts of collagen and glycosaminoglycans.
As such alterations would suggest functional impairment
of growth plate chondrocytes in Tg/agrn¡/¡ mice, we
speciWcally looked for matrix deposition of the major
cartilage matrix components, collagen type II and aggre-
can. Immunohistochemical analysis demonstrated that
both, collagen type II and aggrecan, were indeed slightly
reduced in the growth plates of Tg/agrn¡/¡ mice (Fig. 6a,
b) already at an early postnatal stage. A reduction in
Fig. 2 Shortened bones in Tg/agrn¡/¡ mice. Roentgenological
examination of 16-day-old mice was performed using mammog-
raphy equipment. Tg/agrn¡/¡ mice exhibited shorter long bones
and spine, whereas wild-type and heterozygous animals did not
diVer signiWcantly123
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not shown).
Apoptosis is not increased in Tg/agrn¡/¡ hypertrophic 
chondrocytes
A possible mechanism accounting for the reduced
thickness of the hypertrophic zone in growth plates
from Tg/agrn¡/¡ mice could be an increased apoptosis
rate of hypertrophic chondrocytes. We therefore
decided to look for apoptosis in growth plate cartilage
cells at postnatal day 4. At this developmental stage an
eVect on the hypertrophic zone can already be
observed, yet still suYcient hypertrophic chondrocytes
are present for analysis. We used the terminal deoxy-
nucleotide transferase-mediated dUTP nick end label-
ing (TUNEL) assay to detect DNA strand breaks as an
indicator of apoptosis. Apoptosis rates were extremely
low at this developmental stage in both types of mice,
and no signiWcant diVerences in the apoptosis rates of
hypertrophic chondrocytes could be detected between
control and Tg/agrn¡/¡ mice (Fig. 7).
Decreased chondrocyte proliferation in the growth 
plates of Tg/agrn¡/¡ mice
As apoptosis of hypertrophic chondrocytes was not
increased in Tg/agrn¡/¡ mice, a decreased diVerentia-
tion of chondrocytes to hypertrophic chondrocytes
could account for the observed reduced thickness of
the hypertrophic zone. This assumption is also sup-
ported by the delayed formation of the secondary ossi-
Wcation center described above (Fig. 5d, e). However,
as we did not observe an increase in the thickness of
the proliferative zone, we then had to expect decreased
proliferation of chondrocytes as well. By immunostain-
ing for the PCNA, we could indeed observe that chon-
drocyte proliferation is decreased by approximately
50% in Tg/agrn¡/¡ mice (Fig. 8).
Chondrocytes express the muscle-speciWc kinase 
MuSK
At the NMJ, agrin’s postsynapse-inducing activity is
mediated by the muscle-speciWc kinase MuSK
(DeChiara et al. 1996). To examine whether MuSK is
expressed by chondrocytes as well, we performed RT-
PCR using primers speciWc for MuSK. Indeed, PCR
products for MuSK were found in these cells (Fig. 9).
Furthermore, MuSK expression could also be detected
in human chondrocytes (data not shown). Although
MuSK does not bind directly to agrin, activation of
MuSK is only observed with agrin-B/z+ isoforms (Glass
et al. 1996). To determine which agrin isoforms are
expressed by chondrocytes, primers Xanking the diVer-
ent splice site were used for ampliWcation. Expected
Fig. 3 Agrin is expressed by chondrocytes and is localized in the
growth plate of wild-type mice. Using total RNA prepared from
isolated murine chondrocytes, agrin expression was detected by
means of RT-PCR (a). Sections from paraYn-embedded decalci-
Wed tissue were immunostained using agrin-speciWc antiserum. In
the femoral growth plate of 4-day-old wild-type mice agrin was
predominantly localized to the zones of prehypertrophic chon-
drocytes and proliferating chondrocytes (b). Some unspeciWc
staining of metaphyseal bone was also visible in Tg/agrn¡/¡ mice
(c). Primary antibody was omitted in the negative control (d). Bar
100 m123
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alternatively spliced) 184 bp; for agrin 19/20 (alterna-
tive usage of acceptor site in exon 20) 221 and 248 bp;
for agrin 27/29 (alternative splicing of exon 28, y-site)
200 and 212 bp; and for agrin 31/34 (alternative splicing
of exons 32 and 33, z-site) 184, 208, 217, and 241 bp. As
shown in Fig. 9, only transcripts lacking inserts at the
A/y- and B/z-site could be detected in chondrocytes. In
summary, our results show that both, MuSK and agrin,
are expressed in chondrocytes.
Discussion
In this work, we examined the role of agrin in the early
postnatal development of mice. As agrin mutant mice
die at birth, we used transgenic expression of chick
agrin in motor neurons to overcome the lethality. As
described elsewhere in detail, the mice used in this
study, Tg/agrn¡/¡ mice, lack all endogenous agrin iso-
forms outside of the NMJ (I. Ksiazek et al., manuscript
in preparation). We Wnd that agrin plays an important
Fig. 4 Histological analysis reveals altered growth plate mor-
pholgy in Tg/agrn¡/¡ mice. Sections from paraYn-embedded
decalciWed tissue from 4-day (a–h) and 53-day (i–p) old mice were
stained with hematoxylin/eosin (HE: a, e, i, m), by Masson–Gold-
ner staining (MG: b, f, j, n), with safranin O (SO: c, g, k, o), and
with alcian blue (AB: d, h, l, p), respectively. In tibial growth
plates from 4-day-old Tg/agrn¡/¡ mice (e–h), shortening of the
hypertrophic zone (H) can be seen, while the proliferating zone
(P) is essentially unchanged. In the growth plates from 53-day-old
Tg/agrn¡/¡ mice, no continuous hypertrophic zone, but rather iso-
lated hypertrophic chondrocytes are present. Safranin O and al-
cian blue staining is reduced in the growth plates from Tg/agrn¡/
¡ mice at P53 (o, p), indicating a lower glycosaminogycan content.
Bar 100 m123
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tion. This is a novel Wnding because development of
agrin-deWcient embryos has been reported to proceed
normally and, except for a slight decrease in embryo
size (Serpinskaya et al. 1999), no gross abnormalities in
any tissue were reported (Gautam et al. 1996). More-
over, to the best of our knowledge, this work demon-
strates for the Wrst time that agrin is expressed in the
developing skeletal system.
The most striking eVect of agrin deWciency on skele-
tal development was a marked growth deWciency.
Although the weight of Tg/agrn¡/¡ mice was already
reduced at birth, the diVerences became statistically
signiWcant only 4 days after birth and were very pro-
nounced after 2 weeks. Normal growth in mice has
been shown to continue until the age of 6 months,
resulting in a Wnal weight of approximately 30 g (Som-
erville et al. 2004). In contrast, Tg/agrn¡/¡ mice ceased
Fig. 5 No changes in collagen 
type X in hypertrophic chon-
drocytes of Tg/agrn¡/¡ mice. 
Sections from paraYn-
embedded decalciWed tissue 
of 6-day-old mice were immu-
nostained using collagen type 
X-speciWc antiserum. Both 
wild-type animals (a, d) and 
Tg/agrn¡/¡ mice (b, e) exhibit 
prominent staining of the 
zone of hypertrophic chon-
drocytes at the proximal tibia. 
However, whereas there was a 
clearly discernible secondary 
ossiWcation center in wild-type 
animals (d), this secondary 
ossiWcation center was absent 
in Tg/agrn¡/¡ mice (e) at this 
stage. Primary antibody was 
omitted in the negative con-
trol (c). Bars 50 m (a–c), 
100 m (d, e)
Fig. 6 Collagen type II and 
aggrecan are slightly reduced 
in the cartilage matrix from 
Tg/agrn¡/¡ mice. Sections 
from paraYn-embedded 
decalciWed tissue of 1-day-old 
(collagen type II staining) and 
4-day-old (aggrecan staining) 
mice were immunostained us-
ing collagen type II and aggre-
can-speciWc antiserum, 
respectively. Primary anti-
body was omitted in the nega-
tive controls. Bar 100 m 
(aggrecan staining) and 50 m 
(collagen type II staining), 
respectively123
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only 7 g. Restoration of agrin expression in motor neu-
rons of agrin-deWcient mice re-established the func-
tionality of neuromuscular synapses, thus allowing the
mice to reach an age of up to 3 months. However, we
did observe that NMJs in some of the muscles, includ-
ing the diaphragm, were not innervated properly
(I. Ksiazek et al., manuscript in preparation). These
data indicate that incomplete restoration of NMJ
function could contribute to the increased lethality of
Tg/agrn¡/¡ mice. In bones, the morphological correlate
of the growth retardation was a marked compression of
the hypertrophic zone in the growth plates. Though the
eVects of agrin deWciency on growth became most
apparent postnatally and growth plates of the proximal
tibia appeared morphologically normal at embryonic
day 17 (data not shown), alterations in the composition
of the cartilage matrix could already be observed
prenatally. Morphological changes of the growth plate
were also evident only a few days after birth, when the
thickness of the hypertrophic zone was reduced by
approximately 30%. Thus, although some of the over-
all growth deWcits and the decreased longevity of
Tg/agrn¡/¡ mice might be due to the incomplete resto-
ration of NMJs, the fact that most of the morphological
changes in bone can already be observed in young ani-
mals strongly argues for a direct role of agrin in bone
development.
Growth retardation has been observed in several
mutant mice where either structural components of
cartilage or regulatory molecules have been targeted.
For example, mice deWcient of perlecan, which like
agrin is a large heparan sulfate proteoglycan, have
severe osteochondrodysplasia that manifests itself
between embryonic day 15 and birth (Costell et al.
1999). In these mice the size of long bones is reduced
by approximately 50%, and growth plates are disorga-
nized, lacking the typical columnar arrangement of
hypertrophic chondrocytes. However, both the reduc-
tion in size of long bones as well as the morphological
Fig. 7 Hypertrophic chon-
drocytes in Tg/agrn¡/¡ mice 
do not undergo increased 
apoptosis. Sections from par-
aYn-embedded decalciWed 
tissue of 4-day-old mice were 
subjected to TUNEL-stain-
ing. Positive controls (POS) 
were stained after pretreat-
ment with DNase I; in nega-
tive controls (NEG), terminal 
deoxynucleotide transferase 
was omitted from the incuba-
tion mixture. Bar 100 m123
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the perlecan-deWcient mice than in the agrin-deWcient
mice. Based on the similarities in the skeletal defects of
perlecan- and Col2a1-deWcient mice (Aszodi et al.
1998), a role for perlecan in the protection of the ECM
of cartilage had been proposed, though an increased
activity of gelatinases (MMP-2 and MMP-9) could not
be demonstrated (Gustafsson et al. 2003). Importantly,
our Tg/agrn¡/¡ mice also exhibit a slightly reduced col-
lagen type II density that is secondary to agrin loss.
Other mice mutant in structural components of carti-
lage that show growth retardation are mice carrying a
dominant-negative mutation or a targeted deletion of
collagen type X, which is speciWcally expressed by
hypertrophic chondrocytes (Gress and Jacenko 2000;
Jacenko et al. 1993; Kwan et al. 1997). In these mice,
again in contrast to Tg/agrn¡/¡ mice, the compression
of the growth plate is conWned to zones of resting and
proliferating chondrocytes.
Mutants impinging on the local regulation of the
growth plate aVect, for example, Indian hedgehog. Syn-
thesized by prehypertrophic chondrocytes during prena-
tal development, indian hedgehog acts both in a PTHrP-
dependent and independent fashion. By inducing the
expression of PTHrP in periarticular perichondrial cells,
it initiates a negative regulatory loop controlling the
diVerentiation of proliferating chondrocytes (Vortkamp
et al. 1996). Analysis of indian hedgehog-deWcient mice
has also revealed a direct eVect on chondrocyte prolifer-
ation and osteoblast maturation (St-Jacques et al. 1999).
However, due to the rather low expression levels of
indian hedgehog in the postnatal growth plate (Iwasaki
et al. 1997), the signiWcance of this system for regulation
of postnatal bone development has been questioned.
Another local regulatory system for the growth plate
consists of FGFR3 and its putative ligand FGF-18. For
example, mutations that constitutively activate FGFR3
cause achondroplasia, the most common genetic form of
dwarWsm in humans (Rousseau et al. 1994). Studies
using mice that express a constitutively active FGFR3
under the control of regulatory elements from the colla-
gen type II gene revealed that FGFR3 acts primarily by
inhibiting chondrocyte proliferation and by slowing
chondrocyte diVerentiation, at least in part by downre-
gulation of the indian hedgehog signaling pathway and
of BMP-4 (Naski et al. 1998). Consistent with this dual
activity, these mice have reduced zones of proliferating
and hypertrophic chondrocytes. Tg/agrn¡/¡ mice reiter-
ate this phenotype only partially as they have a reduced
zone of hypertrophic chondrocytes, but the proliferative
zone is not aVected.
It is important to note that growth plate morphology
is not signiWcantly altered in Tg/agrn¡/¡ mice until late
Fig. 8 Lower proliferative activity in chondrocytes from
Tg/agrn¡/¡ mice. Sections from paraYn-embedded decalciWed tis-
sue of 4-day-old mice were immunostained using PCNA-speciWc
antiserum. Bar 100 m
Fig. 9 Chondrocytes express the z¡ isoform of agrin and the mus-
cle-speciWc kinase MuSK. Using total RNA prepared from iso-
lated murine chondrocytes, MuSK expression (size of the
ampliWcation product 193 bp) was detected by means of RT-PCR.
From the size of the ampliWcation product for the z-site (Agrin 31/
34), it is evident that chondrocyte agrin does not contain an insert
at this site (expected sizes of the ampliWcation products are 184 bp
(no insert), 208 bp, 217 bp, and 241 bp, respectively)123
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trophic zone become more pronounced with age. This
indicates that late but not early steps in bone morpho-
genesis are agrin dependent. From a theoretical point
of view, the compression of the hypertrophic zone in
our Tg/agrn¡/¡ mice could result either from a reduced
viability of hypertrophic chondrocytes in the absence of
agrin or by a reduced diVerentiation of chondrocytes to
hypertrophic chondrocytes. We could not Wnd any evi-
dence for increased apoptosis of hypertrophic chondro-
cytes in Tg/agrn¡/¡ mice, indicating that agrin does not
aVect chondrocyte viability. However, the observed
delayed formation of the secondary ossiWcation center
supports the idea that agrin deWciency eVects hypertro-
phic diVerentiation of chondrocytes. Impaired chon-
drocyte diVerentiation should lead to an increasing
thickness of the proliferative zone, unless proliferation
rates were aVected by agrin deWciency, too. Consistent
with our observation that proliferative zones were not
signiWcantly diVerent in Tg/agrn¡/¡ mice, we found
chondrocyte proliferation to be reduced in the absence
of agrin. Importantly, in wild type animals agrin local-
izes predominantly to those zones in the growth plate
where proliferation of chondrocytes and diVerentiation
to hypertrophic chondrocytes occurs.
How agrin exerts its eVects in the growth plate is not
known. At the NMJ, agrin synthesized by presynaptic
motor neurons triggers the formation of postsynaptic
structures via the muscle-speciWc receptor tyrosine
kinase (MuSK). Though MuSK is expressed by mouse
and human chondrocytes (Fig. 9 and H.-J. Hausser,
unpublished data), activation of MuSK is believed to
require the agrin B/z+-isoforms of agrin. We could not
detect such agrin isoforms in chondrocytes. Whether
activation of MuSK could be achieved by agrin isolated
from these cells remains to be determined. However, it
has recently been shown that agrin synthesized by
T cells also lacks an insert at the B/z+-site though it has
been reported to induce clustering of acetylcholine
receptors on cultured myotubes (Khan et al. 2001).
Signaling events downstream of MuSK activation
are only poorly understood. However, the recent
observation that MuSK interacts with Dishevelled and
that this interaction is required for agrin-induced ace-
tylcholine receptor aggregation (Luo et al. 2002) might
be of great interest in the context of agrin’s eVect on
skeletal development for two reasons. First, a Frizzled-
like cysteine-rich domain is found in the extracellular
domain of MuSK and its two closest relatives, ROR1
and ROR2 (Masiakowski and Yancopoulos 1998;
Saldanha et al. 1998), and it has therefore been sug-
gested that Wnt-like ligands may bind to these recep-
tors. Indeed, in C. elegans a receptor tyrosine kinase,
LIN-18, has recently been shown to function as a Wnt
receptor in parallel to LIN-17/Frizzled (Inoue et al.
2004). Secondly, an increasing number of reports high-
light the importance of Wnt-signaling for the regula-
tion of chondrocyte proliferation and diVerentiation
(Church et al. 2002; Yang et al. 2003). Given the simi-
larities of events that depend on proper Wnt-signaling
and, as shown in this manuscript, on agrin signaling, it
is tempting to speculate that the agrin-MuSK-system
and the Wnt-system might interact in the regulation of
skeletal development and bone formation. Here, Wnt-
ligands might represent the hypothesized accessory
factors required for agrin signaling, or, vice versa, agrin
might be required for Wnt-signaling. Undoubtedly, this
question deserves further investigation.
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